Our vision, “to deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines globally", encapsulates the Group’s inherent approach of conducting business ethically, with integrity and with a commercial wisdom which strives to enhance the economic and social well-being of our patients, consumers, investors, employees, customers and business partners.
OUR APPROACH TO SUSTAINABILITY
We are committed to creating value for all of our stakeholders in a manner that is responsible, transparent and respects the rights of all. We recognise that to achieve long-term success, we need to deliver our business strategy in a way that creates value not only to Aspen and our shareholders, but also to society and the planet.
Our sustainability commitments
We believe that doing business in a sustainable and responsible manner is integral to our purpose, our values and our philosophy "Healthcare. We Care". Our sustainability commitments are integrated into the Group's strategic objectives and underpin the way we do business. Our sustainability commitments are determined with consideration to the following key aspects:
UN Global Compact
We are signatories to the UN Global Compact and have aligned our sustainability commitments with the principles outlined in the UN Global Compact, which cover human rights, labour, environment and anti-corruption. Our Communication on Progress report, available online, sets out our approach to the application of these principles.
United Nations Sustainable Development Goals ("SDGs")
Launched in September 2015, the United Nations 2030 Agenda for Sustainable Development is a global action plan for people, planet and prosperity. The 17 SDGs aim to tackle the world's most pressing challenges through the promotion of sustainable development. As a multinational pharmaceutical company, we have an important role in contributing to the delivery of the SDGs. While all of the SDGs are essential, we have identified eight goals where we believe we are able to have the greatest impact, and linked these to our sustainability themes and material sustainability topics.
Material sustainability topics
We performed a sustainability related materiality assessment to identify the sustainability issues that are most critical to our business and our stakeholders. This process assists us in identifying sustainability focus areas and informs our strategy and the content of our reporting. We align our identification of material sustainability topics with the GRI standards, UN Global Compact, the FTSE/JSE Responsible Investor Index assessment criteria as well as considering information relating to the pharmaceutical sector; our regulatory requirements and matters raised during engagement with our people and our external stakeholders.
Our sustainability themes
We have grouped our sustainability commitments into four key themes:
Assurance in respect of the sustainability KPIs is obtained by means of a combined assurance approach, with IBIS providing assurance on the key environmental, health and safety indicators in line with the AccountAbility AA1000 Assurance Standard, PwC providing assurance on the financial indicators and other assurance providers such as the Group’s Internal Audit and Empowerdex providing assurance on the balance of the indicators reported.
2020 Supplementary Sustainability Documents:
•Sustainability Data Supplement 2020 PDF 859KB
•Climate Change CDP PDF 455KB
•Water Security CDP PDF 422KB
•Environmental Management Principles PDF 145KB
•Equity Report - Fine Chemicals Workforce Profile PDF 70KB
•Equity Report - South African Operations Workforce Profile PDF 70KB
•IBIS Assurance Statement PDF 179KB
2020 Safety and environmental certifications:
•Bad Oldesloe - OHSAS 50001 PDF 1.2MB
•Bad Oldesloe - ISO 14001 PDF 1.3MB
•Bad Oldesloe - ISO 45001 PDF 1.3MB
•Dandenong - ISO 14001 PDF 510KB
•Dandenong - OHSAS 18001 PDF 512KB
•FCC - ISO 14000 PDF 37KB
•FCC - ISO 45001 PDF 36KB
•Notre Dame de Bondeville - ISO 14001 PDF 584KB
•Notre Dame de Bondeville - ISO 50001 PDF 800KB
•Notre Dame de Bondeville - ISO 45001 PDF 801KB
•OSS - ISO 14001 PDF 227KB
•OSS - OHSAS 45001 PDF 141KB
•South African Operations - ISO 14001 PDF 757KB
•South African Operations - OHSAS 18001 PDF 98KB
•Vitória - ISO 14001 PDF 1.5MB
•Vitória - OHSAS 18001 PDF 313KB
We are committed to enhancing access to medicines and providing reliable supply of quality products, improving the health and quality of life of patients and enhancing access across the geographies of our operations.
We are committed to creating a healthy and safe work environment, where everyone is treated fairly and with respect and has the opportunity to develop to their full potential.
We strive to operate an ethical and responsible business underpinned by our shared values and governance structures. We uphold the dignity, fundamental freedoms and human rights of our employees, contractors and the communities in which we live and work, and others affected by our activities.
We are committed to practising responsible environmental stewardship, seeking to minimise any negative impact our operations have on the environment and to comply with applicable laws, regulations and other environmental management requirements.